Holdings
Schwab Health Care Fund
As of Jul 31, 2026, Schwab Health Care Fund reported 80 positions worth US$636M. Largest: Eli Lilly and Company, Johnson & Johnson and AbbVie Inc. What it bought and sold, with each filing.
Holdings
- Part of
- Schwab
- Positions
- 80
- Value as reported
- US$636M
- Holdings as of
- Jul 31, 2026
- Last filed
- Sep 24, 2026
| Company | Shares | Value as reported | % of portfolio | Change | As of |
|---|---|---|---|---|---|
| Eli Lilly and Company NYSE:LLY | 77,841 | US$89.4M | 13.9% | −1,115 | Jul 31, 2026 |
| Johnson & Johnson NYSE:JNJ | 174K | US$44.6M | 6.9% | −19,021 | Jul 31, 2026 |
| AbbVie Inc. NYSE:ABBV | 149K | US$37.3M | 5.8% | −21,968 | Jul 31, 2026 |
| Merck & Company, Inc. NYSE:MRK | 246K | US$32M | 5.0% | no change | Jul 31, 2026 |
| UnitedHealth Group Incorporated NYSE:UNH | 73,427 | US$30.4M | 4.7% | +11,143 | Jul 31, 2026 |
| Gilead Sciences, Inc. NASDAQ:GILD | 160K | US$20.8M | 3.2% | −24,628 | Jul 31, 2026 |
| Novartis AG SIX:NOVN | 120K | US$18.8M | 2.9% | −4,173 | Jul 31, 2026 |
| Amgen Inc. NASDAQ:AMGN | 43,091 | US$16.6M | 2.6% | −3,530 | Jul 31, 2026 |
| Bristol-Myers Squibb Company NYSE:BMY | 240K | US$15.7M | 2.4% | +119K | Jul 31, 2026 |
| Medtronic plc. NYSE:MDT | 172K | US$14.7M | 2.3% | −32,962 | Jul 31, 2026 |
| Roche Holding Ltd SIX:RO | 33,618 | US$14.7M | 2.3% | −2,291 | Jul 31, 2026 |
| Thermo Fisher Scientific Inc NYSE:TMO | 24,108 | US$13.8M | 2.2% | no change | Jul 31, 2026 |
| Stryker Corporation NYSE:SYK | 41,586 | US$13.5M | 2.1% | −9,684 | Jul 31, 2026 |
| Vertex Pharmaceuticals Incorporated NASDAQ:VRTX | 25,379 | US$12.1M | 1.9% | +1,320 | Jul 31, 2026 |
| GSK plc LSE:GSK | 427K | US$11.1M | 1.7% | −74,774 | Jul 31, 2026 |
| Boston Scientific Corporation NYSE:BSX | 220K | US$10.3M | 1.6% | +25,393 | Jul 31, 2026 |
| Abbott Laboratories NYSE:ABT | 97,408 | US$10.3M | 1.6% | +29,077 | Jul 31, 2026 |
| The Cigna Group NYSE:CI | 34,774 | US$9.7M | 1.5% | −4,601 | Jul 31, 2026 |
| Danaher Corporation NYSE:DHR | 48,332 | US$9.42M | 1.5% | +13,445 | Jul 31, 2026 |
| Elevance Health, Inc. NYSE:ELV | 24,845 | US$9.34M | 1.5% | +21,172 | Jul 31, 2026 |
| Incyte Corporation NASDAQ:INCY | 73,854 | US$8.83M | 1.4% | +22,168 | Jul 31, 2026 |
| Ipsen SA EURONEXT:IPN | 44,466 | US$8.59M | 1.3% | +9,271 | Jul 31, 2026 |
| Sanofi SA EURONEXT:SAN | 97,498 | US$8.4M | 1.3% | +44,171 | Jul 31, 2026 |
| Becton, Dickinson and Company NYSE:BDX | 48,036 | US$7.96M | 1.2% | +4,160 | Jul 31, 2026 |
| Astellas Pharma Inc. TSE:4503 | 555K | US$7.63M | 1.2% | −14,300 | Jul 31, 2026 |
| Jazz Pharmaceuticals plc NASDAQ:JAZZ | 29,378 | US$7.43M | 1.2% | +23,003 | Jul 31, 2026 |
| AstraZeneca PLC LSE:AZN | 42,820 | US$7.28M | 1.1% | −19,578 | Jul 31, 2026 |
| McKesson Corporation NYSE:MCK | 8,050 | US$6.89M | 1.1% | −3,293 | Jul 31, 2026 |
| STERIS plc (Ireland) NYSE:STE | 28,872 | US$6.59M | 1.0% | −4,530 | Jul 31, 2026 |
| IQVIA Holdings, Inc. NYSE:IQV | 27,860 | US$6.55M | 1.0% | −6,181 | Jul 31, 2026 |
| Cardinal Health, Inc. NYSE:CAH | 28,069 | US$6.46M | 1.0% | −8,187 | Jul 31, 2026 |
| HealthEquity, Inc. NASDAQ:HQY | 62,072 | US$6.25M | 0.97% | −12,606 | Jul 31, 2026 |
| CVS Health Corporation NYSE:CVS | 58,631 | US$6.12M | 0.95% | new | Jul 31, 2026 |
| Exelixis, Inc. NASDAQ:EXEL | 112K | US$5.92M | 0.92% | −47,215 | Jul 31, 2026 |
| United Therapeutics Corporation NASDAQ:UTHR | 11,322 | US$5.86M | 0.91% | no change | Jul 31, 2026 |
| IDEXX Laboratories, Inc. NASDAQ:IDXX | 10,363 | US$5.79M | 0.90% | +1,627 | Jul 31, 2026 |
| ResMed Inc. NYSE:RMD | 25,092 | US$5.29M | 0.82% | no change | Jul 31, 2026 |
| HCA Healthcare, Inc. NYSE:HCA | 12,961 | US$5.22M | 0.81% | −6,027 | Jul 31, 2026 |
| BrightSpring Health Services, Inc. NASDAQ:BTSG | 79,281 | US$4.73M | 0.74% | −15,200 | Jul 31, 2026 |
| Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | 6,059 | US$4.62M | 0.72% | −8,884 | Jul 31, 2026 |
| Koninklijke Philips N.V. EURONEXT:PHIA | 174K | US$4.59M | 0.71% | +34,704 | Jul 31, 2026 |
| Neurocrine Biosciences, Inc. NASDAQ:NBIX | 26,394 | US$4.4M | 0.69% | +20,194 | Jul 31, 2026 |
| Veracyte, Inc. NASDAQ:VCYT | 87,202 | US$4.04M | 0.63% | −26,963 | Jul 31, 2026 |
| Agilent Technologies, Inc. NYSE:A | 27,455 | US$3.8M | 0.59% | −15,000 | Jul 31, 2026 |
| Hoya Corporation TSE:7741 | 24,000 | US$3.67M | 0.57% | −7,000 | Jul 31, 2026 |
| ANI Pharmaceuticals, Inc. NASDAQ:ANIP | 43,420 | US$3.44M | 0.54% | no change | Jul 31, 2026 |
| BioMarin Pharmaceutical Inc. NASDAQ:BMRN | 49,405 | US$2.97M | 0.46% | +22,939 | Jul 31, 2026 |
| Innoviva, Inc. NASDAQ:INVA | 132K | US$2.76M | 0.43% | no change | Jul 31, 2026 |
| Axsome Therapeutics, Inc. NASDAQ:AXSM | 12,357 | US$2.69M | 0.42% | +2,679 | Jul 31, 2026 |
| Smith & Nephew plc LSE:SN. | 169K | US$2.64M | 0.41% | −51,186 | Jul 31, 2026 |
| Natera, Inc. NASDAQ:NTRA | 9,725 | US$2.6M | 0.41% | −8,200 | Jul 31, 2026 |
| Intuitive Surgical, Inc. NASDAQ:ISRG | 7,152 | US$2.53M | 0.39% | no change | Jul 31, 2026 |
| Ascendis Pharma A/S NASDAQ:ASND | 9,761 | US$2.38M | 0.37% | new | Jul 31, 2026 |
| Align Technology, Inc. NASDAQ:ALGN | 13,600 | US$2.3M | 0.36% | new | Jul 31, 2026 |
| Novo Nordisk A/S Class B OMXCOP:NOVO_B | 45,699 | US$2.16M | 0.34% | +15,846 | Jul 31, 2026 |
| Asahi Intecc Co., Ltd. TSE:7747 | 90,900 | US$2.05M | 0.32% | +21,000 | Jul 31, 2026 |
| BioCryst Pharmaceuticals, Inc. NASDAQ:BCRX | 176K | US$1.58M | 0.25% | no change | Jul 31, 2026 |
| Ambea AB OMXSTO:AMBEA | 94,458 | US$1.43M | 0.22% | no change | Jul 31, 2026 |
| Universal Health Services, Inc. NYSE:UHS | 8,100 | US$1.36M | 0.21% | new | Jul 31, 2026 |
| Krystal Biotech, Inc. NASDAQ:KRYS | 3,714 | US$1.27M | 0.20% | new | Jul 31, 2026 |
| Travere Therapeutics, Inc. NASDAQ:TVTX | 22,405 | US$1.25M | 0.19% | new | Jul 31, 2026 |
| Chugai Pharmaceutical Co., Ltd. TSE:4519 | 28,000 | US$1.21M | 0.19% | no change | Jul 31, 2026 |
| Pegavision Corp. TWSE:6491 | 120K | US$1.19M | 0.19% | new | Jul 31, 2026 |
| Biogen Inc. NASDAQ:BIIB | 5,732 | US$1.16M | 0.18% | −3,500 | Jul 31, 2026 |
| Aurinia Pharmaceuticals Inc NASDAQ:AUPH | 75,100 | US$1.12M | 0.17% | no change | Jul 31, 2026 |
| Fisher & Paykel Healthcare Corporation Limited NZX:FPH | 40,000 | US$957K | 0.15% | −35,402 | Jul 31, 2026 |
| Amneal Pharmaceuticals, Inc. NASDAQ:AMRX | 50,864 | US$932K | 0.15% | no change | Jul 31, 2026 |
| DexCom, Inc. NASDAQ:DXCM | 9,200 | US$768K | 0.12% | new | Jul 31, 2026 |
| Halozyme Therapeutics, Inc. NASDAQ:HALO | 8,998 | US$743K | 0.12% | new | Jul 31, 2026 |
| Liquidia Corporation NASDAQ:LQDA | 8,240 | US$693K | 0.11% | new | Jul 31, 2026 |
| Hikma Pharmaceuticals PLC LSE:HIK | 30,760 | US$657K | 0.10% | new | Jul 31, 2026 |
| AnaptysBio, Inc. NASDAQ:ANAB | 11,939 | US$637K | 0.10% | no change | Jul 31, 2026 |
| Hugel, Inc. KRX:145020 | 3,776 | US$609K | 0.09% | no change | Jul 31, 2026 |
| Xeris Biopharma Holdings, Inc. NASDAQ:XERS | 51,241 | US$414K | 0.06% | no change | Jul 31, 2026 |
| Consun Pharmaceutical Group Ltd. HKEX:1681 | 193K | US$337K | 0.05% | −900K | Jul 31, 2026 |
| Medipal Holdings Corporation TSE:7459 | 17,900 | US$322K | 0.05% | new | Jul 31, 2026 |
| Attendo AB OMXSTO:ATT | 25,000 | US$288K | 0.04% | new | Jul 31, 2026 |
| Mirum Pharmaceuticals, Inc. NASDAQ:MIRM | 2,435 | US$258K | 0.04% | −12,300 | Jul 31, 2026 |
| Elekta AB Class B OMXSTO:EKTA_B | 49,962 | US$254K | 0.04% | no change | Jul 31, 2026 |
| GE HealthCare Technologies Inc. NASDAQ:GEHC | 2,800 | US$190K | 0.03% | −148K | Jul 31, 2026 |